Financial Statements

Strongbridge Biopharma plc (SBBP)

$2

+0.03 (+1.52%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2020 2019 2018 2017 2016
Retained Earnings (Previous Year) -260-211-243-129-
Net Income -45-4932-113-49
Stock Dividends -----81
Dividend Paid -----
Retained Earnings -306-260-211-243-129

PPE Schedule

Year 2020 2019 2018 2017 2016
Gross PPE 1000-
Annual Depreciation -011-00
Capital Expenditure -0-0-0--
Net PPE 11000

Intangible and Goodwill Schedule

Year 2020 2019 2018 2017 2016
Intangible and Goodwill (Previous Year) -7777
New Purchases ----56-
Intangible and Goodwill 77777

Strongbridge Biopharma plc income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Strongbridge Biopharma plc FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.